New insurance year? Re-check the authorization before the first expensive treatment of the year.

A new plan year can bring a new medical policy, preferred product, site-of-care rule, network, deductible or claims administrator. Whether an existing authorization carries forward is plan-specific.

The safest approach is to treat the first treatment under a new benefit year as a deliberate re-verification point rather than assuming last year’s approval still controls.

Verify the plan before verifying the drug

Confirm the member ID, group number, payer, claims administrator and effective date. Employer plans can keep a familiar insurer logo while changing the underlying plan or administrator.

If the plan changed, the clinic may need a new authorization even if the medicine, prescriber and diagnosis did not change.

Re-check product and site preference

Plans can change preferred biosimilars, specialty-pharmacy requirements or site-of-care rules. Ask what product and setting are authorized for the new benefit year.

If the plan requires a different product, do not switch based only on an insurance phone call. The prescriber and treatment site must confirm the clinically and operationally appropriate authorized product.

Re-estimate patient responsibility separately

A new deductible or out-of-pocket accumulation can change the patient’s early-year cost even when coverage is unchanged. Manufacturer or foundation assistance eligibility may also need to be reverified.

Keep coverage approval and financial-assistance renewal as two separate checklists so one does not hide a gap in the other.

Use the source that actually controls your case

MedicineCostHelp can organize the problem, but the member-specific plan, payer decision, provider record or assistance program makes the actual determination. Keep written decisions, reference numbers and the documents that support the next step.